Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study
GHDx Entry last modified on: Mar 22, 2024
COVID-19
Dataset Records for COVID-19
Displaying 951 - 1000 of 1636
Incidence, clinical, risk factors and outcomes of Guillain-Barré in Covid-19
GHDx Entry last modified on: Oct 23, 2024
Mexico Health Secretary COVID-19 Daily Technical Report 2020
Comunicado Técnico Diario COVID-19 MÉXICO
Novel coronavirus epidemic in the Hungarian population, a cross-sectional nationwide survey to support the exit policy in Hungary
GHDx Entry last modified on: Mar 14, 2022
Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2
GHDx Entry last modified on: Mar 14, 2022
Point prevalence of SARS-CoV-2 and infection fatality rate in Orleans and Jefferson Parish, Louisiana, May 9-15, 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
The role of essential organ-based comorbidities in the prognosis of COVID-19 infection patients
GHDx Entry last modified on: Mar 14, 2022
Prevalence and reversibility of smell dysfunction measured psychophysically in a cohort of COVID-19 patients
GHDx Entry last modified on: Mar 14, 2022
Coronavirus disease 2019 in pregnant women: a report based on 116 cases
GHDx Entry last modified on: Jan 31, 2024
Update on clinical outcomes of women with COVID-19 during pregnancy
GHDx Entry last modified on: Jan 31, 2024
Impact of Covid-19 in pregnancy on mother's psychological status and infant's neurobehavioral development: a longitudinal cohort study in China
GHDx Entry last modified on: Mar 8, 2024
Testing of Patients and Support Persons for Coronavirus Disease 2019 (COVID-19) Infection Before Scheduled Deliveries
GHDx Entry last modified on: Jan 31, 2024
Findings from serological surveys (in August 2020) to assess the exposure of adult population to SARS Cov-2 infection in three cities of Odisha, India. Preprint.
GHDx Entry last modified on: Mar 14, 2022
Pronounced difference in Covid-19 antibody prevalence indicates cluster transmission in Stockholm, Sweden
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of antibodies against SARS-CoV-2 among public community and health-care workers in Alzintan City of Libya. Preprint
GHDx Entry last modified on: Mar 14, 2022
Three-quarters attack rate of SARS-CoV-2 in the Brazilian Amazon during a largely unmitigated epidemic
GHDx Entry last modified on: Jan 31, 2024
Brazil - Rio Grande do Norte COVID-19 Epidemiological Report 2021
Informe Epidemiológico Coronavírus (Covid-19)
Seropositive Prevalence of Antibodies Against SARS-CoV-2 in Wuhan, China
GHDx Entry last modified on: Jan 31, 2024
Serology- and PCR-based cumulative incidence of SARS-CoV-2 infection in adults in a successfully contained early hotspot (CoMoLo study), Germany, May to June 2020
GHDx Entry last modified on: Jan 31, 2024
Searching for COVID-19 Antibodies in Czech Children-A Needle in the Haystack
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020. Preprint
GHDx Entry last modified on: Mar 14, 2022
Charting Elimination in the Pandemic: A SARS-CoV-2 Serosurvey of Blood Donors in New Zealand. Preprint
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 IgG in asymptomatic and pauci-symptomatic people over a 5 month survey in Argentina
GHDx Entry last modified on: Mar 14, 2022
High prevalence of anti-SARS-CoV-2 antibodies after the first wave of COVID-19 in Kinshasa, Democratic Republic of the Congo: results of a cross-sectional household-based survey
GHDx Entry last modified on: Jan 18, 2024
A three-phase population based sero-epidemiological study: Assessing the trend in prevalence of SARS-CoV-2 during COVID-19 pandemic in Jordan
GHDx Entry last modified on: May 12, 2022
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020. Preprint
GHDx Entry last modified on: May 12, 2022
Dyspnoea, lung function and CT findings 3months after hospital admission for COVID-19
GHDx Entry last modified on: Apr 10, 2023
Differences in seroprevalence between epicenter and non-epicenter areas of the COVID-19 outbreak in South Korea
GHDx Entry last modified on: Mar 14, 2022
Onset, duration and unresolved symptoms, including smell and taste changes, in mild COVID-19 infection: a cohort study in Israeli patients
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of SARS-CoV-2 infection in a municipality in southern Brazil
GHDx Entry last modified on: Jan 31, 2024
Estimation of real-infection and immunity against SARS-CoV-2 in Indian populations. Preprint
GHDx Entry last modified on: Apr 8, 2022
SARS-CoV-2 PCR positivity rate and seroprevalence of related antibodies among a sample of patients in Cairo: Pre-wave 2 results of a screening program in a university hospital
GHDx Entry last modified on: Mar 14, 2022
Development Assistance for Health on COVID-19 2020
GHDx Entry last modified on: Oct 20, 2022
Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers
GHDx Entry last modified on: Mar 14, 2022
Comparison of Estimated SARS-CoV-2 Seroprevalence through Commercial Laboratory Residual Sera Testing and a Community Survey
GHDx Entry last modified on: Jan 31, 2024
Citywide serosurveillance of the initial SARS-CoV-2 outbreak in San Francisco. Preprint
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 exposure in Malawian blood donors: an analysis of seroprevalence and variant dynamics between January 2020 and July 2021
GHDx Entry last modified on: May 12, 2022
Finland COVID-19 Cases in the Infectious Disease Registry 2020-2022
COVID-19 Cases in the Infectious Disease Registry
Disease registry:
Epi surveillance
Impact of Recommended Maternal Vaccination Programs on the Clinical Presentation of SARS-CoV-2 Infection: A Prospective Observational Study
GHDx Entry last modified on: Apr 10, 2023
Management of pregnant women with COVID-19: A tertiary pandemic center experience on 1416 cases
GHDx Entry last modified on: Apr 10, 2023
Maternal and perinatal outcomes of pregnant women with SARS-CoV-2 infection at the time of birth in England: national cohort study
GHDx Entry last modified on: Jan 31, 2024
Spanish registry of Covid-19 screening in asymptomatic pregnants.
GHDx Entry last modified on: Apr 10, 2023
Major impact of COVID-19 national containment on activities in the French northern comprehensive cancer center
GHDx Entry last modified on: Apr 10, 2023
Practical Applicability of the ISARIC-4C Score on Severity and Mortality due to SARS-CoV-2 Infection in Patients with Type 2 Diabetes
GHDx Entry last modified on: Dec 12, 2023
Post-acute sequelae of COVID-19 in a non-hospitalized cohort: Results from the Arizona CoVHORT
GHDx Entry last modified on: Mar 22, 2024
Symptom Burden and Immune Dynamics 6 to 18 Months Following Mild Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2): A Case-control Study
GHDx Entry last modified on: Mar 22, 2024
Postdischarge rheumatic and musculoskeletal symptoms following hospitalization for COVID-19: prospective follow-up by phone interviews
GHDx Entry last modified on: Mar 22, 2024
Symptoms of Long-COVID 1-Year after a COVID-19 outbreak among sailors on a French aircraft carrier
GHDx Entry last modified on: Mar 22, 2024
Effect of Different Factors on the Quality of Life and Sequelae of COVID-19 Patients after Discharge
GHDx Entry last modified on: Mar 22, 2024
Subscribe